1
Mucosal and Microbiota Changes During Acute Campylobacteriosis
Condition(s):Irritable Bowel SyndromeLast Updated:August 18, 2020Recruiting
Campylobacter Infections: 17 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Efficacy of Rifaximin in Preventing Campylobacteriosis
Condition(s):Dysentery; Diarrhea; Enteric CampylobacteriosisLast Updated:November 20, 2018Completed
3
Campylobacter Jejuni Challenge Model Development: Dose Ranging Study
Condition(s):Campylobacter InfectionsLast Updated:June 5, 2008Unknown status
4
Retrospective Study of Bone Infection Due to Campylobacter Spp
Condition(s):Campylobacter Infections; Bone Diseases, InfectiousLast Updated:August 31, 2016Completed
5
Campylobacter Jejuni Challenge Model Development: Assessment of Homologous Protection
Condition(s):Campylobacter InfectionsLast Updated:January 13, 2010Unknown status
6
ACE393-103 Vaccination Challenge Study
Condition(s):Campylobacter InfectionLast Updated:March 11, 2009Unknown status
7
LMN-101 in a Campylobacter Human Challenge Model
Condition(s):Campylobacter InfectionsLast Updated:July 7, 2020Not yet recruiting
8
Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea
Condition(s):Campylobacter InfectionLast Updated:February 23, 2018Completed
9
Campylobacter Enteritis and Post-Infective Bowel Dysfunction (PI-BD): Role of Antibiotics and Microbiota
Condition(s):Campylobacter Infections; Irritable Bowel SyndromeLast Updated:May 4, 2017Unknown status
10
Epidemiology and Pathophysiology of Post-Infectious Functional GI Disorders
Condition(s):Campylobacter Infections; Irritable Bowel SyndromeLast Updated:January 5, 2021Active, not recruiting